All data generated during this study are available in the NCBI SRA repository: PRJNA5446384 (<http://www.ncbi.nlm.nih.gov/bioproject/544638>). All other relevant data are included in this published article.

Introduction {#sec001}
============

Gastrointestinal nematode (GIN) infection is one of the most important economic constraints in small ruminant production. These parasites have a negative impact on animal health and welfare, but their main effect is reduced productivity and thus economic return \[[@pone.0218719.ref001],[@pone.0218719.ref002]\]. For the last 50 years control strategies have been based mainly on the use of anthelmintics but unfortunately, the selection pressure created by their repeated use has led to the rapid development of anthelmintic resistance in GIN populations worldwide \[[@pone.0218719.ref003]--[@pone.0218719.ref005]\]. The constant increase in the prevalence of anthelmintic-resistant GIN strains together with increasing demand for chemical-free animal products and potential environmental consequences of anthelmintics increase the need for novel alternative control strategies. The improvement of host response against GIN through genetic selection of resistant lines or breeds is among the most promising strategies.

The feasibility of different selection programs has been studied, in both temperate and tropical conditions, mainly in sheep and to a lesser extent in goats \[[@pone.0218719.ref001],[@pone.0218719.ref006],[@pone.0218719.ref007]\]. Selection is in most studies mainly based on fecal egg count (FEC), however, some selection schemes include other relevant traits such as production and measures of anemia and blood eosinophilia under conditions of either natural or experimental infection with GIN \[[@pone.0218719.ref008]--[@pone.0218719.ref011]\]. Fecal egg count is a moderately heritable trait (h^2^ \~ 0.3) for which response to selection has been shown in sheep and also in goats \[[@pone.0218719.ref001]\]. Despite numerous studies comparing intra- or inter-breed resistance variation in small ruminants \[[@pone.0218719.ref012]--[@pone.0218719.ref015]\], the detailed mechanisms involved in genetic resistance remain unclear. One challenge for the coming years is the identification of new biological resistance and/or susceptibility markers to improve the efficiency and timeliness of breeding programs. Comparative transcriptomic analysis is a pertinent method for understanding the molecular genetic basis of complex traits such as host resistance. Several previous studies have been undertaken to identify genes and biological processes associated with the host response to GIN in the duodenum \[[@pone.0218719.ref016]--[@pone.0218719.ref018]\] and the abomasal mucosa \[[@pone.0218719.ref019],[@pone.0218719.ref020]\] and the draining lymph nodes \[[@pone.0218719.ref021]--[@pone.0218719.ref025]\]. Although goats are more susceptible to GIN infections than sheep, most of the research programs have aimed to investigate host-GIN interactions in sheep. The need for more studies on the goat model has become increasingly important since it was reported that goats develop a different set of strategies than sheep to regulate parasitic infections \[[@pone.0218719.ref026]\], and they may differ in the sequence for establishing immunity \[[@pone.0218719.ref027]\].

The aim of the present study was to identify the molecular pathways involved in the response of Creole goats to GIN infection by analyzing the transcriptomes of abomasal mucosa and draining lymph nodes of infected versus non-infected and resistant versus susceptible kids.

Materials and methods {#sec002}
=====================

Ethics statement {#sec003}
----------------

All animal care handling techniques and procedures as well as the license for experimental infection, blood sampling and slaughtering were approved by INRA, according to the certificate number A-971-18-02 of authorization to experiment on living animals issued by the French Ministry of Agriculture, before the initiation of the experiment.

Animals and experimental design {#sec004}
-------------------------------

Twenty four 10-month old Creole kids with limited natural GIN infection (FEC \< 100) were reared indoors at the experimental facility of INRA in Guadeloupe (PTEA, Plateforme Tropicale pour l'expérimentation Animale). Animals had been bred for resistant and susceptible to GIN according to estimated breeding values of FEC. The average predicted breeding values on FEC of the resistant and susceptible kids differed by 1.04 genetic standard deviation (n = 12 resistant and n = 12 susceptible). Two consecutive challenges of 7 weeks with a 4 week interval between the end of challenge 1 and the start of challenge 2 were carried out ([Fig 1](#pone.0218719.g001){ref-type="fig"}). For each challenge, kids were orally infected with a single dose of 10,000 *Haemonchus contortus* third-stage larvae (L3) at Day 0. A group of 6 kids (n = 3 resistant and n = 3 susceptible) from the 24 animals was used as non-infected controls. Fecal and blood samples from each animal were recovered once a week during the course of the experimental infection. At the end of the second infection (42 days post infection), animals with extreme FEC measured during the infection (6 resistant and 6 susceptible) and 3 non-infected control animals were slaughtered with a penetrating captive bolt immediately followed by exsanguination for sampling of abomasal mucosa and lymph nodes tissue and GIN burdens quantification ([Fig 1](#pone.0218719.g001){ref-type="fig"}).

![Experimental design.\
S, susceptible; R, resistant; Non, non-infected.](pone.0218719.g001){#pone.0218719.g001}

Parasitological techniques and blood samples {#sec005}
--------------------------------------------

FEC was determined using a modified McMaster technique for rapid determination as described by Aumont \[[@pone.0218719.ref028]\]. Blood samples (2 x 3 ml) were individually collected once a week from each animal by using disposable syringes and 20-Ga needles in two plastic tubes (one coated with EDTA, ethylenediamine tetraacetic acid K3, Becton Dickinson, Plymouth, UK) by jugular venipuncture. Blood samples previously placed in EDTA coated tubes were used to measure the number of circulating eosinophils according to the method of Dawkins \[[@pone.0218719.ref009]\] with a Malassez cell counter. The packed cell volume (PCV) was measured using the capillary microhaematocrit method. Blood samples collected in plastic tubes without EDTA (serum tubes; Becton Dickinson) were centrifuged for 5 min. at 5000 rpm then serum were frozen at -20°C until analysis. Serum pepsinogen levels were determined using a micromethod for routine determination according to Dorny and Vercruysse \[[@pone.0218719.ref029]\]. At slaughter the abomasum contents were stored in 5% formalin for total male, female and worm burden counts. Samples of the fundic abomasum and the draining lymph nodes tissues (approximatively 1cm X 1cm) were collected with a sterile scalpel and snap frozen in liquid nitrogen then stored at -80°C until total RNA extraction.

RNA extraction and quality analysis {#sec006}
-----------------------------------

Total RNA was extracted from frozen tissues samples using the NucleoSpin RNA isolation kit (Macherey-Nagel, Hoerdt, France) in accordance with the manufacturer's instructions, except DNase incubation which was performed with twice the indicated amount of enzyme. The total RNA concentration was measured with NanoDrop 2000 (ThermoScientific TM, France) and the quality was quantified using a Agilent 2100 Bioanalyzer (Agilent Technologies, France). The extracted total RNA was stored at -80°C until use.

Library preparation and sequencing {#sec007}
----------------------------------

High-quality RNA (RIN \> 7.5) from all tissues samples (abomasal mucosa and lymph nodes) was used for the preparation of cDNA libraries according to Illumina's protocols (Illumina TruSeq RNA sample prep kit for mRNA analysis). Briefly, poly-A mRNA was purified from 4μg of total RNA, fragmented and randomly primed for reverse transcription to generate double stranded cDNA. The cDNA fragments were then subjected to an end repair process, consisting of the addition of a single 'A' base, and the ligation of indexed Illumina adapters at both ends of cDNA. These products were then purified and enriched by PCR to create the final barcoded cDNA library. After quality control and quantification, cDNA libraries were pooled in groups of 6 and sequenced on 5 lanes on the HiSeqTM 2000 (Illumina NEB, USA) to obtain approximatively 30 million reads (100 bp paired-end) for each sample with insert sizes ranging from 200 to 400 base pairs.

Quality control and read mapping to the reference genome {#sec008}
--------------------------------------------------------

The quality control check on raw reads in FASTQ format were processed using FASTQC and the Q20, Q30 and GC contents of the clean data were calculated. The sequences obtained by RNA-Seq were splice-aligned, for each library, using STAR (version 2.3.0e with standard parameters) \[[@pone.0218719.ref030]\]. The reads were mapped to the *Capra hircus* genome (assembly ARS1). The resulting alignment files were merged to produce a global splice alignment reference with samtools sort, merge and index (version 0.1.19-44428cd using standard parameters). This reference was processed using the Cufflinks program \[[@pone.0218719.ref031]\] (version v2.1.1 with standard parameters and Ensembl [ref_CHIR_1.0_top_level.gtf](http://ng6.toulouse.inra.fr/fileadmin/data/analyze/d26350921/ref_CHIR_1.0_top_level.gtf) as reference) to identify expressed transcripts and genes. The reference transcript and gene model files were used to quantify the expression in each library with featureCounts (version 1.4.5-p1 using standard parameters) \[[@pone.0218719.ref032]\]. The same reference was used for all samples. The resulting count files were merged using Unix cut and paste commands to produce a global count file on which the statistical analyses were performed. The three outputs of this first part of the process gathered the count file, the reference transcriptome file and the unaligned read sets.

Expression profiling {#sec009}
--------------------

Differentially expressed genes (DEG) of read counts were identified using the Bioconductor package DESeq2 \[[@pone.0218719.ref033]\] run within the R software (v3.4.1). Four comparisons were performed: 1- mucosa tissue from infected versus non-infected animals; 2- lymph node tissue from infected versus non-infected animals; 3- mucosa tissue from infected resistant versus infected susceptible animals and 4- lymph node tissue from infected resistant versus infected susceptible animals. Low expression tags were filtered, keeping only genes that achieved at least 5 counts in each condition. To account for multiple testing, genes were filtered using a Benjamini and Hochberg false discovery rate (FDR) of \< 0.001.

Gene ontology (GO) and pathway enrichment analysis {#sec010}
--------------------------------------------------

GO analysis was used as an international standardized gene functional classification system to describe properties of genes and their products. DEG are functionally grouped into the three GO domains (biological processes, cellular components, and molecular processes) looking for significantly enriched functions compared to the genomic background. GO enrichment analysis and GO annotations plotting were performed using the clusterProfiler R-package. Due to the lack of goat (*Capra hircus*) GO data, GO were analyzed based on human annotation. All enriched GO terms that possessed a p-value \< 0.01 were displayed.

The Kyoto Encyclopedia of Genes and Genomes (KEGG) is the major public pathway database of biological systems that integrates genomic, chemical and systemic functional information \[[@pone.0218719.ref034]\]. KEGG pathway enrichment analyses were performed using DAVID \[[@pone.0218719.ref035],[@pone.0218719.ref036]\]. Pathways with a Q-value \< 0.05 were considered significant. Moreover, analysis of canonical pathways and regulator effects as well as network analysis were performed using Ingenuity pathway analysis (IPA) software (Ingenuity Systems, Redwood City, CA) for DEG in each comparison.

Quantitative real-time PCR (qRT-PCR) validation {#sec011}
-----------------------------------------------

Gene expression of 7 genes (n = 5 for the abomasal mucosa and n = 5 for the lymph nodes; 3 genes were common to both tissues) was measured by q-PCR in order to validate the results obtained in the RNAseq analysis. Goat ACTB (actin beta) gene whose expression remained stable among the samples was used as the endogenous control for all reactions. A total of 2 μg of high quality total RNA (RIN \> 7.5) was used to synthetize the cDNA using M-MLV Reverse Transcriptase (Promega, Charbonières, France) according to the manufacturer's instructions. All qPCR reactions were carried out in 48-well plates in a Prime Pro 48 Real-Time PCR System and analyzed with the ProStudy Software v5.2.10 (Techne, Staffordshire, UK). Taqman predesigned gene expression assay ([Table 1](#pone.0218719.t001){ref-type="table"}) and the universal PCR master mix were purchased from Applied Biosystems and the analyses were performed according to the manufacturer's instructions (ThermoFisher Scientific, Applied Biosystems, Courtaboeuf, France). Samples were analyzed in duplicate in a total volume of 20 μl containing: 4 μl of cDNA, 10 μl of 2X TaqMan Fast Advanced Master Mix, 1 μl of TaqMan Gene Expression Assays 20X (ThermoFisher Scientific, Applied Biosystems, Courtaboeuf, France) and 5 μl of distilled RNAse DNAse-free water. Relative gene expression values were determined using relative quantification (2^-ΔΔCt^ method, \[[@pone.0218719.ref037]\]).

10.1371/journal.pone.0218719.t001

###### List of target genes for qPCR validation and assay IDs according to the manufacturer.

![](pone.0218719.t001){#pone.0218719.t001g}

  Gene symbol    Gene description                              Assay IDs
  -------------- --------------------------------------------- ---------------
  *ACTB*         *actin beta*                                  Ch04810274_s1
  *CCL20*        *C-C motif chemokine ligand 20*               Ch04791475_m1
  *CLEC4E*       *C-type lectin domain family 4*, *member e*   Ch04688119_m1
  *Galectin-9*   *LOC102189615*                                Ch04788979_m1
  *IFI6*         *interferon alpha inducible protein 6*        Ch04807049_g1
  *IL13*         *interleukin 13*                              Ch04684348_m1
  *PGLYRP1*      *peptidoglycan recognition protein 1*         Ch04786957_m1
  *TLR4*         *toll-like receptor 4*                        Ch04654181_m1

Statistical analysis on the phenotypic data {#sec012}
-------------------------------------------

The FEC variable was log transformed in order to normalize its variance. The statistical analyses of the phenotypic (FEC, eosinophilia, pepsinogen and PCV) differences between animals in the infected, non-infected, resistant and susceptible groups were tested by using PROC MIXED in SAS (v. 9.4, SAS Inst. Inc., Cary, NC, USA, 2012) and differences were considered significant when *P* \< 0.05. The results are presented after back-transformation. The association between parasitological (number of males, number of females, worm burden and establishment rate) and physiological (FEC, eosinophilia, pepsinogen and PCV) variables at slaughter were determined using Pearson's correlation coefficient (v. 9.4, SAS Inst. Inc., Cary, NC, USA, 2012).

Results and discussion {#sec013}
======================

Phenotypic and parasitological measurements {#sec014}
-------------------------------------------

The packed cell volume (PCV) values significantly decreased during the first challenge in both resistant and susceptible kids until 28 days post-infection (d.p.i.) with no significant difference between the groups ([Fig 2a](#pone.0218719.g002){ref-type="fig"}). A small decrease was observed during the second challenge in both groups, with values significantly different than control kids from day 28 to 42 post-infection ([Fig 2b](#pone.0218719.g002){ref-type="fig"}). During the second infection, the PCV was negatively correlated with establishment rate (*r* = -0.66, *P* \< 0.01) and other physiological variables, including fecal egg counts (FEC) (*r* = -0.47, *P* \< 0.01), eosinophilia (*r* = -0.30, *P* \< 0.01) and pepsinogen (*r* = -0.40, *P* \< 0.01 [Table 2](#pone.0218719.t002){ref-type="table"}). Similar correlations between PCV and FEC were previously reported in sheep infected with *H*. *contortus* in Florida Native, Rambouillet sheep and their crossbreed (*r* = -0.45) \[[@pone.0218719.ref038]\] and in Pelibuey sheep (*r* = -0.35, *P* \< 0.01) \[[@pone.0218719.ref039]\]. A stronger negative correlation *(r* = -0.78) was reported for Caribbean hair sheep and conventional wool sheep \[[@pone.0218719.ref040]\].

![Least square means of fecal egg counts (FEC) and packed cell volume (PCV) in resistant (r) and susceptible (s) Creole kids infected with 10,000 *H*. *contortus* larvae (L3) and non-infected (n) animals.\
(a) first infection, (b) second infection.](pone.0218719.g002){#pone.0218719.g002}

10.1371/journal.pone.0218719.t002

###### Correlation coefficients between parasitological and physiological variables at slaughter.

![](pone.0218719.t002){#pone.0218719.t002g}

                       FEC                                         Eosinophilia                                Pepsinogen                                  PCV
  -------------------- ------------------------------------------- ------------------------------------------- ------------------------------------------- --------------------------------------------
  Male                 0.61[\*](#t002fn001){ref-type="table-fn"}   0.62[\*](#t002fn001){ref-type="table-fn"}   0.57[\*](#t002fn001){ref-type="table-fn"}   -0.61[\*](#t002fn001){ref-type="table-fn"}
  Female               0.66[\*](#t002fn001){ref-type="table-fn"}   0.64[\*](#t002fn001){ref-type="table-fn"}   0.58[\*](#t002fn001){ref-type="table-fn"}   -0.61[\*](#t002fn001){ref-type="table-fn"}
  Worm burden          0.63[\*](#t002fn001){ref-type="table-fn"}   0.63[\*](#t002fn001){ref-type="table-fn"}   0.58[\*](#t002fn001){ref-type="table-fn"}   -0.61[\*](#t002fn001){ref-type="table-fn"}
  Establishment rate   0.41                                        0.64[\*](#t002fn001){ref-type="table-fn"}   0.73[\*](#t002fn001){ref-type="table-fn"}   -0.66[\*](#t002fn001){ref-type="table-fn"}
  FEC                                                              0.12                                        0.03                                        -0.47[\*](#t002fn001){ref-type="table-fn"}
  Eosinophilia                                                                                                 0.30[\*](#t002fn001){ref-type="table-fn"}   -0.30[\*](#t002fn001){ref-type="table-fn"}
  Pepsinogen                                                                                                                                               -0.40[\*](#t002fn001){ref-type="table-fn"}

\* P \< 0.05. FEC: fecal egg counts. PCV: packed cell volume

The FEC remained at zero until 14 d.p.i. in both resistant and susceptible groups during both the first ([Fig 2a](#pone.0218719.g002){ref-type="fig"}) and second infection ([Fig 2b](#pone.0218719.g002){ref-type="fig"}). Susceptible kids had significantly higher FEC than resistant kids during the second infection ([Fig 2b](#pone.0218719.g002){ref-type="fig"}). No significant differences between resistant and susceptible kids in worm burden (1669±673 and 2556±673, respectively), male worm count (1042±392 and 1371±392, respectively), female worm count (627±285 and 1186±285, respectively) or establishment rate (12.35±6.75 and 19.70±6.75, respectively) were observed in samples from kids slaughtered at the end of the second challenge. The correlations of worm burden with FEC (r = 0.63, P \< 0.05) and PCV (r = -0.61, P \< 0.05) were similar to those previously reported in sheep \[[@pone.0218719.ref038],[@pone.0218719.ref040]\].

These results suggested that the adaptive immune response influences genetic resistance which is expressed during the second experimental infection but not during the first one. In keeping with a previous study the lower FEC observed in resistant compared with susceptible kids was not correlated with differences in worm burden and establishment rate \[[@pone.0218719.ref011]\]. The control of fecundity in goats is probably driven by other mechanisms than IgA activity \[[@pone.0218719.ref041]\] in contrast with sheep in which IgA was suggested to be the major mechanism controlling GIN fecundity \[[@pone.0218719.ref042],[@pone.0218719.ref043]\].

In sheep, numerous studies have shown that eosinophil response is associated with local IgA response to control GIN fecundity \[[@pone.0218719.ref042],[@pone.0218719.ref044],[@pone.0218719.ref045]\]. In this experiment, there was no significant correlation of eosinophilia and pepsinogen with FEC. However, eosinophilia and pepsinogen showed significant positive correlations with male worm count (*r* = 0.62 and *r* = 0.57, P \< 0.05, respectively), female worm count (*r* = 0.64 and *r* = 0.58, P \< 0.05, respectively), worm burden (*r* = 0.63 and *r* = 0.58, P \< 0.05, respectively) and establishment rate (*r* = 0.64 and *r* = 0.73, P \< 0.05, respectively, [Table 2](#pone.0218719.t002){ref-type="table"}). The positive correlations in goats compared to the negative correlations in sheep suggest that different mechanisms are involved in the genetic resistance in goats and sheep.

Transcriptome analysis {#sec015}
----------------------

### 1. RNA sequencing {#sec016}

Sequencing of the RNA samples resulted in an average of 8.8±2.0 million reads per sample aligned to a unique region of the goat genome. These reads corresponded to 21399 genes of the *C*. *hircus* genome (assembly ARS1). A total of 15007 to 15585 genes had at least 5 counts in goat abomasal and lymph node tissues. These genes were subsequently used in the comparative analysis.

### 2. Differential gene expression {#sec017}

The number of DEG in each comparison is shown in [Table 3](#pone.0218719.t003){ref-type="table"}. The number of DEG was higher in lymph node tissue compared with mucosa tissue in both comparisons (infected versus non-infected (1726 and 792) and resistant versus susceptible (450 and 342, respectively). Meanwhile, the fold change range was on average higher in the mucosal tissue compared with lymph node tissue. Human orthologues were mapped for 82--89% of the DEG and these orthologues were used for the GO and IPA analysis ([Table 3](#pone.0218719.t003){ref-type="table"}).

10.1371/journal.pone.0218719.t003

###### Number of genes differentially expressed for each comparison.

![](pone.0218719.t003){#pone.0218719.t003g}

  Comparison                FDR \< 0.001   Log2 fold change range   Human orthologs
  ------------------------- -------------- ------------------------ -----------------
  Inf. vs non-inf. mucosa   792            -22.77, 4.55             648 (82%)
  Inf. vs non-inf. lymph    1726           -9.41, 4.84              1519 (88%)
  Res. vs sus. mucosa       342            -4.38, 8.19              303 (89%)
  Res. vs sus. lymph        450            -2.67, 2.39              384 (85%)

FDR, false discovery rate.

The number of DEG identified in our study was relatively high compared to RNA sequencing studies of lymph node tissues comparing resistant and susceptible sheep \[[@pone.0218719.ref024],[@pone.0218719.ref025]\] and lower than the number of DEG in the blood transcriptome of resistant and susceptible goats \[[@pone.0218719.ref046]\]. There may be variations among species and tissues. However, Bhuiyan \[[@pone.0218719.ref046]\] used fold change values ≥ 2.5 or ≤ -2.0 as the basis to identify DEG, while we used all significant DE genes on the basis of a FDR \< 0.001.

Functional classification analysis {#sec018}
----------------------------------

### 1. Gene ontology (GO) {#sec019}

An enriched GO term analysis including 'biological processes', 'molecular functions', and 'cellular components' was performed using the DEG from each comparison. The top 5 significant functional groups in each term are presented in Figs [3](#pone.0218719.g003){ref-type="fig"} and [4](#pone.0218719.g004){ref-type="fig"}. The top significant biological processes for the DEG identified using the comparison of mucosa tissue from non-infected and infected animals were chromosome segregation and mitotic nuclear division, while it was blood vessel morphologenesis and angiogenesis for the comparison between resistant and susceptible animals using the same tissue. Post-transcriptional regulation of gene expression was the top significant biological process for DEG identified in abomasal lymph node tissue of infected versus non-infected kids and resistant versus susceptible kids.

![Top 5 biological processes that changed among groups.\
Infected versus non-infected (Inf. vs non-inf.), resistant versus susceptible (Res. vs sus.).](pone.0218719.g003){#pone.0218719.g003}

![Top 5 cellular components and molecular functions that changed among groups.\
Infected versus non-infected (Inf. vs non-inf.), resistant versus susceptible (Res. vs sus.).](pone.0218719.g004){#pone.0218719.g004}

The second, third and fourth top biological functions for the DEG identified from the comparison of lymph node tissue from resistant and susceptible goats were related to antigen processing and presentation of peptide antigen via major histocompatibility complex (MHC) class I ([Fig 3](#pone.0218719.g003){ref-type="fig"}). The 'antigen processing and presentation of peptide antigen via MHC class I' was also reported as one of the major functional annotation cluster of genes differentially expressed in abomasal lymph nodes in sheep breeds known to differ in GIN resistance \[[@pone.0218719.ref024]\]. The implication of the MHC Class I molecules in the mechanisms underlying genetic resistance to *H*. *contortus* was reported through an association between reduction in FEC and a homozygotes allele for the MHC class I (*OMHC1-188*) in sheep \[[@pone.0218719.ref039]\]. MHC class I present intracellular peptides at the cell surface to CD8+ T cells when intracellular pathogens such as viruses induce cellular expression of viral proteins. Some of these viral proteins are tagged for degradation, with the resulting peptide fragments entering the endoplasmic reticulum and binding to MHC class I molecules \[[@pone.0218719.ref047]\]. Meanwhile, MHC class II present peptides from extra-cellular pathogens at the cell surface of CD4+ T cells which help to trigger an appropriate immune response including localized inflammation or lead to a full-force antibody immune response due to activation of B cells \[[@pone.0218719.ref047]\]. Our results in goats and other results from previous studies in sheep \[[@pone.0218719.ref024],[@pone.0218719.ref039]\] suggest that MHC class I plays a role in resistance to GIN infection. Moreover, other studies in goats indicated that humoral response is not correlated with GIN resistance in goats \[[@pone.0218719.ref041],[@pone.0218719.ref048],[@pone.0218719.ref049]\].

The complexes peptidase, proteasome and endopeptidase were the top three significant cellular components for the DEG in abomasal lymph node tissue of both infected versus non-infected kids and resistant versus susceptible kids, which reflects the role of MHC class I. The top significant molecular function terms for the comparison of mucosa tissue from susceptible and resistant kids were growth factor binding and glycosaminoglycan binding while for lymph node tissue it was translation factor activity, RNA binding and translation initiation factor activity ([Fig 4](#pone.0218719.g004){ref-type="fig"}). Growth factor binding was found to be one of the most enriched molecular functions while comparing blood from resistant and susceptible goats \[[@pone.0218719.ref046]\]. The translation initiation factor activity pathway was previously found to be associated with genes more highly expressed in samples from the duodenum of susceptible compared with resistant sheep \[[@pone.0218719.ref018]\].

### 2. Pathway enrichment analysis {#sec020}

The Ingenuity pathway analysis identified 96 significant canonical pathways for the DEG for mucosa and 94 for lymph node samples from infected versus non-infected kids, and 37 pathways for mucosa and 35 for lymph node samples in the comparison of resistant versus susceptible kids. The KEGG pathway enrichment analysis on the other hand identified 25 (mucosa) and 22 (lymph node) pathways in infected versus non-infected kids, and 11 (mucosa) and 8 (lymph node) significant pathways for resistant versus susceptible kids. The top 5 canonical pathways for each comparison group are presented in [Table 4](#pone.0218719.t004){ref-type="table"} and the top 5 KEGG pathways in [Table 5](#pone.0218719.t005){ref-type="table"}. The overlap ratio (the number of DEG involved in a particular pathway divided by the total number of genes in that pathway) was in general higher for KEGG than that for the canonical pathways.

10.1371/journal.pone.0218719.t004

###### Top 5 significant canonical pathways identified by Ingenuity pathway analysis using DE genes.

![](pone.0218719.t004){#pone.0218719.t004g}

  Comparison                                              Ingenuity Canonical Pathways        P value    Overlap ratio[^a^](#t004fn001){ref-type="table-fn"}
  ------------------------------------------------------- ----------------------------------- ---------- -----------------------------------------------------
  Infected versus non-infected mucosa                     Mitotic Roles of Polo-Like Kinase   5.50E-06   0.18
  Eicosanoid Signaling                                    4.60E-05                            0.15       
  Role of CHK Proteins in Cell Cycle Checkpoint Control   6.69E-05                            0.16       
  Cell Cycle: G2/M DNA Damage Checkpoint Regulation       1.73E-04                            0.16       
  Hereditary Breast Cancer Signaling                      2.20E-04                            0.10       
  Infected versus non-infected lymph                      Protein Ubiquitination Pathway      1.55E-09   0.19
  Factors Promoting Cardiogenesis in Vertebrates          2.39E-06                            0.24       
  Molecular Mechanisms of Cancer                          5.98E-06                            0.14       
  STAT3 Pathway                                           3.10E-05                            0.23       
  Adipogenesis pathway                                    5.34E-05                            0.18       
  Resistant versus susceptible mucosa                     Osteoarthritis Pathway              3.93E-06   0.07
  Human Embryonic Stem Cell Pluripotency                  6.54E-05                            0.07       
  Factors Promoting Cardiogenesis in Vertebrates          7.07E-05                            0.09       
  Hepatic Fibrosis / Hepatic Stellate Cell Activation     1.23E-04                            0.06       
  Regulation of the Epithelial-Mesenchymal Transition     1.63E-04                            0.06       
  Resistant versus susceptible lymph                      Protein Ubiquitination Pathway      5.89E-05   0.06
  EIF2 Signaling                                          2.56E-04                            0.06       
  Regulation of eIF4 and p70S6K Signaling                 8.35E-04                            0.07       
  Granzyme B Signaling                                    3.31E-03                            0.19       
  Cell Cycle Regulation by BTG Family Proteins            4.46E-03                            0.11       

^a^ The ratio is calculated by taking the number of DE genes that participate in a Canonical Pathway, and dividing it by the total number of genes in that Canonical Pathway.

10.1371/journal.pone.0218719.t005

###### Top 5 significant KEGG pathways identified by DAVID using DE genes.

![](pone.0218719.t005){#pone.0218719.t005g}

  Comparison                                    DAVID KEEG Pathways                     P value    Overlap ratio[^a^](#t005fn001){ref-type="table-fn"}
  --------------------------------------------- --------------------------------------- ---------- -----------------------------------------------------
  Infected versus non-infected mucosa           Cell cycle                              3.20E-06   0.14
  Fructose and mannose metabolism               1.20E-04                                0.25       
  Amino sugar and nucleotide sugar metabolism   4.10E-04                                0.18       
  Fat digestion and absorption                  1.10E-03                                0.18       
  Protein export                                1.80E-03                                0.24       
  Infected versus non-infected lymph            Protein export                          3.10E-09   0.60
  Protein processing in endoplasmic reticulum   1.10E-08                                0.24       
  Proteasome                                    5.70E-08                                0.40       
  Biosynthesis of antibiotics                   8.00E-04                                0.16       
  Central carbon metabolism in cancer           3.20E-03                                0.22       
  Resistant versus susceptible mucosa           Regulation of lipolysis in adipocytes   2.50E-04   0.13
  PI3K-Akt signaling pathway                    2.40E-03                                0.04       
  TGF-beta signaling pathway                    3.50E-03                                0.08       
  PPAR signaling pathway                        6.90E-03                                0.08       
  Malaria                                       1.10E-02                                0.10       
  Resistant versus susceptible lymph            Proteasome                              1.20E-06   0.21
  Carbon metabolism                             2.90E-04                                0.10       
  Biosynthesis of antibiotics                   3.30E-04                                0.07       
  Ribosome biogenesis in eukaryotes             2.30E-03                                0.10       
  RNA transport                                 4.70E-03                                0.07       

^a^ The ratio is calculated by taking the number of DE genes that participate in a KEGG Pathway, and dividing it by the total number of genes in that KEGG Pathway.

The cell cycle pathway was one of the most significant pathways identified by canonical or KEGG pathways for the DEG identified in mucosa tissue from infected versus non-infected kids (Tables [4](#pone.0218719.t004){ref-type="table"} and [5](#pone.0218719.t005){ref-type="table"}). The protein ubiquitination pathway was the most significant canonical pathway for DEG in lymph node tissue in both the comparison of infected versus non-infected and of resistant versus susceptible kids ([Table 4](#pone.0218719.t004){ref-type="table"}). Meanwhile, proteasome and biosynthesis of antibiotics were in the top KEGG pathways for the same comparisons ([Table 5](#pone.0218719.t005){ref-type="table"}).

We found that the 'Cell Cycle Regulation by BTG Family Proteins' pathway was one of the most significant canonical pathways identified for DEG in abomasum lymph node tissue from susceptible versus resistant kids. The same pathway was identified as significantly impacted during parasitic infection in the abomasum of resistant cattle \[[@pone.0218719.ref050]\]. Transforming growth factor beta (TGF-β) is a multifunctional cytokine belonging to a super family including three different isoforms (*TGFβ1*, *TGFβ2*, *TGFβ3*), which are related to the TGF-β signaling pathway besides many other signaling proteins produced by all white blood cells lineages and it is best known for its regulatory activity and induction of peripheral tolerance \[[@pone.0218719.ref051]\]. Recently, it was shown that the cytokine profile modulated by *rHCcyst-3* increases the secretion of *IL-10* and *TGF-ß1* in goat monocytes. This contributes to induce an anti-inflammatory environment which is favorable for worm survival \[[@pone.0218719.ref052]\]. The 'TGF-β signaling pathway' was reported to be a significant pathway regulated by DEG identified in blood of resistant versus susceptible goats \[[@pone.0218719.ref046]\]. We found that the 'TGF- β signaling pathway' was in the top 5 significant KEGG pathways and in the top 10 canonical pathways for the DEG in the comparison of mucosa samples between resistant and susceptible kids. Moreover, Transforming growth factor beta-1 (*TGFβ1*) was the first upstream regulator gene that was differently expressed in mucosa tissue of resistant versus susceptible and the fifth in infected versus non-infected kids, with a prediction to be inhibited in resistant kids ([Table 6](#pone.0218719.t006){ref-type="table"}). TGF-β receptor 1 was reported as highly expressed in lymph node samples of wool (susceptible) sheep compared with hair (resistant) sheep at 27 day post infection with *H*. *contortus* \[[@pone.0218719.ref021]\].

10.1371/journal.pone.0218719.t006

###### Top 5 upstream regulators identified by Ingenuity pathway analysis using DE genes.

![](pone.0218719.t006){#pone.0218719.t006g}

  Comparison                            Upstream regulator   P value     Predicted Activation
  ------------------------------------- -------------------- ----------- ----------------------
  Infected versus non-infected mucosa   *ERBB2*              9.06E-14    Inhibited
  *RABL6*                               1.08E-13             Inhibited   
  *NUPR1*                               1.21E-11             Activated   
  *FOXM1*                               2.66E-11             Inhibited   
  *TGFβ1*                               1.40E-10                         
  Infected versus non-infected lymph    *CST5*               2.38E-05    
  *SYVN1*                               5.41E-05                         
  *FSH*                                 6.42E-05                         
  *XBP1*                                2.65E-04             Inhibited   
  *ESR1*                                3.20E-04                         
  Resistant versus susceptible mucosa   *TGFβ1*              4.71E-14    Inhibited
  *beta-estradiol*                      3.05E-11             Inhibited   
  *FGF2*                                6.60E-11                         
  *estrogen*                            7.49E-10                         
  *TAZ*                                 1.22E-09                         
  Resistant versus susceptible lymph    *5-fluorouracil*     1.47E-06    Inhibited
  *HNF4A*                               3.11E-05                         
  *E2F1*                                1.30E-04                         
  *CD 437*                              1.67E-04             Inhibited   
  *valproic acid*                       1.82E-04             Inhibited   

### 3. Genetic associated diseases and networks {#sec021}

The top 5 diseases and biological functions for DEG identified for each comparison are presented in [Fig 5](#pone.0218719.g005){ref-type="fig"}. For all comparisons, 'cancer' and 'organismal injury and abnormalities' were in the top 5 diseases identified by IPA. Comparing infected with non-infected kids we found 'Cell death and survival' in the top molecular and cellular functions for mucosal tissue and lymph node samples. Moreover, molecular and cellular function was also one of the top functions when comparing lymph node tissue from resistant versus susceptible kids despite being exposed to the same GIN population. It was therefore the shared significant biological function for multiple comparisons which mainly controls infection consequences. Figs [6](#pone.0218719.g006){ref-type="fig"} and [7](#pone.0218719.g007){ref-type="fig"} show the DEG that control cell survival as identified in the mucosal tissue from infected versus non-infected ([Fig 6](#pone.0218719.g006){ref-type="fig"}) and resistant versus susceptible kids ([Fig 7](#pone.0218719.g007){ref-type="fig"}). The DEG in the abomasal mucosa, the ecological niche of *H*. *contortus*, were part of pathways for reproductive system diseases for both comparisons of infected versus non-infected and resistant versus susceptible kids. Besides, Beta-estradiol and estrogen were also in the top five upstream regulators genes differently expressed in mucosal tissue of resistant versus susceptible kids ([Table 6](#pone.0218719.t006){ref-type="table"}).

![Top 5 diseases and biological function identified by Ingenuity pathway analysis using DE genes.](pone.0218719.g005){#pone.0218719.g005}

![Genes controlling cell survival that were differently expressed in infected versus non-infected mucosal tissue.](pone.0218719.g006){#pone.0218719.g006}

![Genes controlling cell survival that were differently expressed in resistant versus susceptible mucosal tissue.](pone.0218719.g007){#pone.0218719.g007}

We compared our results for diseases and biological functions with other studies. Four of the top five significant diseases that we identified in the comparison of abomasal mucosa in infected versus non-infected kids were also reported as being significantly different expressed in the abomasal mucosa of 'immune' sheep at day 0 (non-infected) compared with 2 days after infection with *Teladorsagia circumcincta*, another important nematode parasite of sheep and goats \[[@pone.0218719.ref053]\]. Moreover, the same study \[[@pone.0218719.ref053]\] reported the same top 5 molecular and cellular functions that we found for the same comparison (mucosa samples from infected versus non-infected animals). When comparing the lymph node transcriptome using resistant and susceptible sheep infected with *T*. *circumcincta*, the gastrointestinal and hematological diseases were identified to be significant \[[@pone.0218719.ref023]\]. We identified both these functions for the DEG in the same tissue when comparing resistant and susceptible kids. These results indicate that *H*. *contortus* and *T*. *circumcincta* infection in goats and sheep activate the same functions and that the biological process involved are the similar across different hosts and parasites.

The top 5 networks identified by IPA for each comparison are shown in [Table 7](#pone.0218719.t007){ref-type="table"}. The results showed that the abomasal mucosa of infected kids activate or inhibit genes that target 'cell cycle' and 'cell death and survival' networks. It confirms results from canonical and KEGG pathways which identified cell cycle pathways as the most significant pathways. This suggests that the maintenance of the integrity of the mucosa, which is the barrier between the lumen and the organism, is probably the priority for the host. We also found that DEG in lymph node tissues control post-translational modification in infected compared with non-infected kids. Further, DEG control RNA post-transcriptional modification and protein synthesis in resistant compared with susceptible kids ([Table 7](#pone.0218719.t007){ref-type="table"}).

10.1371/journal.pone.0218719.t007

###### Top 5 networks for each comparison identified by Ingenuity pathway analysis using DE genes.

![](pone.0218719.t007){#pone.0218719.t007g}

  Comparison                                                                                                       Network                                                                         IPA Score[^a^](#t007fn001){ref-type="table-fn"}   Genes
  ---------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------- ------------------------------------------------- -------
  Infected versus non-infected mucosa                                                                              Cell Cycle, Reproductive System Development and Function, Cellular Movement     38                                                30
  Cell Cycle, DNA Replication, Recombination, and Repair, Cancer                                                   36                                                                              29                                                
  Cell Cycle, Cellular Assembly and Organization, DNA Replication, Recombination, and Repair                       36                                                                              29                                                
  Cell Death and Survival, Hematological System Development and Function, Cell Signaling                           30                                                                              26                                                
  Cell Signaling, Lipid Metabolism, Small Molecule Biochemistry                                                    30                                                                              26                                                
  Infected versus non-infected lymph                                                                               Cancer, Organismal Injury and Abnormalities, Metabolic Disease                  35                                                34
  Cancer, Organismal Injury and Abnormalities, Respiratory Disease                                                 32                                                                              33                                                
  Post-Translational Modification, Cell Cycle, Neurological Disease                                                32                                                                              33                                                
  Post-Translational Modification, Amino Acid Metabolism, Small Molecule Biochemistry                              30                                                                              32                                                
  Dermatological Diseases and Conditions, Organismal Injury and Abnormalities, Antimicrobial Response              28                                                                              31                                                
  Resistant versus susceptible mucosa                                                                              Cellular Movement, Cellular Development, Embryonic Development                  43                                                26
  Cardiovascular System Development and Function, Organismal Development, Cell-To-Cell Signaling and Interaction   36                                                                              23                                                
  Cancer, Organismal Injury and Abnormalities, Cell Signaling                                                      34                                                                              22                                                
  Cellular Development, Connective Tissue Development and Function, Tissue Development                             32                                                                              21                                                
  Organ Morphology, Skeletal and Muscular System Development and Function, Tissue Morphology                       27                                                                              19                                                
  Resistant versus susceptible lymph                                                                               Protein Synthesis, Molecular Transport, RNA Post-Transcriptional Modification   61                                                34
  Protein Synthesis, Gene Expression, RNA Post-Transcriptional Modification                                        40                                                                              26                                                
  Antimicrobial Response, Inflammatory Response, Developmental Disorder                                            40                                                                              26                                                
  Energy Production, Nucleic Acid Metabolism, Small Molecule Biochemistry                                          37                                                                              25                                                
  Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities                                          33                                                                              23                                                

^a^ IPA network score is expressed as the -log (Fisher's exact test p-value).

Validation of expression by qRT-PCR {#sec022}
-----------------------------------

RNA sequencing results were validated by performing RT-qPCR for seven genes, five from the mucosal tissue (CCL20, IFI6, IL13, galectin 9, TLR4) and five from lymph node tissue (CLEC4E, IFI6, IL13, PGLYRP4, TLR4) for both comparisons of infected versus non-infected and resistant versus susceptible kids. As shown in [Fig 8](#pone.0218719.g008){ref-type="fig"}, the log~2~ fold change levels of selected genes measured by RT-qPCR were in good agreement with the values from the sequencing data. The gene expression patterns from qPCR in mucosa and lymph node tissues were strongly correlated with the sequencing results (correlation coefficient 0.73 and 0.86 respectively).

![Comparison of fold changes of deferentially expressed genes measured by RNA-Seq (black) and qPCR analyses (white) according to the groups (resistant vs. susceptible, R/S and infected vs. non-infected, I/NI) and the tissues (mucosa and lymph nodes).](pone.0218719.g008){#pone.0218719.g008}

Conclusion {#sec023}
==========

Our results suggested that in our biological model, the mechanisms underlying genetic resistance were not expressed during the first challenge. Meanwhile, results from the second challenge suggested that resistance in Creole goats would be primarily mediated through reduced worm fecundity with a probable role for MHC class I. The consequences of infection were mainly controlled through 'Cell death and survival' as the top cell function at this stage of infection (42 d.p.i), which suggests that the maintenance of the integrity of the mucosal barrier is one of the priorities of the host response.
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